17-71112612-G-T

Variant summary

Our verdict is Likely benign.
-4 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -4 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_Strong

The NR_104152.1(CASC17):n.218-12994C>A variant causes a intron, non coding transcript change involving the alteration of a non-conserved nucleotide. Note: NR_104152.1 is not a MANE Select or MANE Plus Clinical transcript for CASC17; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.56 (AC=85,130) in the gnomAD database across 151,984 control chromosomes, including 24,465 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.687. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.56 ( 24465 hom., cov: 32)

Consequence

CASC17
NR_104152.1 intron, non_coding_transcript

Predictors

3
AlphaGenome AVI: 1 : Benign

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.163

Publications

171 publications found
Genes affected
CASC17 (HGNC:43911): ()
ENSG00000300867 (HGNC:):

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NR_104152.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Likely_benign. The variant received -4 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.687 — exceeds 1% threshold (B1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NR_104152.1. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

CASC17 NR_104152.1
HGVSc / HGVSpn.218-12994C>A
Exon rankIntron 3 of 3
intronnon_coding_transcript
Prot:

Ensembl Transcripts

CASC17 ENST00000569074.1
TSL:1
HGVSc / HGVSpn.216-12994C>A
Exon rankIntron 3 of 3
intronnon_coding_transcript
Prot:
CASC17 ENST00000659670.1
HGVSc / HGVSpn.252-12994C>A
Exon rankIntron 3 of 3
intronnon_coding_transcript
Prot:
ENSG00000300867 ENST00000774768.1
HGVSc / HGVSpn.548+2790G>T
Exon rankIntron 2 of 2
intronnon_coding_transcript
Prot:

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.560
AC:85073
Hom:24444
AN:151866
Cov:32
GnomAD4 genome
AF: 0.560
AC:85130
Hom:24465
AN:151984
Cov:32
TOPMed (Bravo)
AF: 0.565
AC:149565
Hom:43332
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.532
AC:397835
Hom:108230
AN:747706
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.544
AC:1273
Hom:346
AN:2342
ChinaMAP Phase 1
AF: 0.590
Denmark Genome
AF: 0.473
AC:142
AN:300
GenomeAsia100K
AF: 0.572
AC:1990
AN:3478
Korea4K (4,157 Koreans)
AF: 0.671
AC:4853
AN:7234
Qatari Genome
AF: 0.489
AC:86
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.739
AC:90735
Hom:33572
AN:122744
Turkish Variome
AF: 0.455
AC:701
Hom:152
AN:1542
UK10K
AF: 0.529
AC:3997
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.596
AC:5338
Hom:1594
AN:8960
Showing 14 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign1.1
BayesDel_noAF
Benign-0.93
CADD
Benign1.1
DANN
Benign0.43
GPN-Star LLR
N/A4.4
GPN-Star score
N/A-0.11
PhyloP100
Benign-0.16
Showing 7 of 7 scores

Splicing Scores

No splicing scores have been computed for this variant.

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.